Juvenile psoriatic arthritis—an analysis of 60 cases

Shore, A; Ansell, Barbara M.

doi:10.1016/s0022-3476(82)80747-6

Cited by 122 publications

(59 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Subsequent clinical series of patients with JPsA remained consistent with the observations of Lambert et al (1976), noting a mean age of onset of 10 -12 years of age, generally older than in populations of patients with JRA (Table I) (Calabro 1977;Sills 1980;Shore and Ansell 1982;Hamilton et al 1990;Truckenbrodt and Hafner 1990). All of these studies confirmed the findings of Lambert et al that arthritis preceded psoriasis in a substantial proportion of patients (23 -58%), often by several years (Table I).…”

supporting

confidence: 78%

“…All of these studies confirmed the findings of Lambert et al that arthritis preceded psoriasis in a substantial proportion of patients (23 -58%), often by several years (Table I). These findings prompted several authors to suggest that criteria should be developed to entertain the diagnosis of JPsA in the absence of psoriasis (Sills 1980;Shore and Ansell 1982). Southwood et al (1989), answered the call for more inclusive criteria for JPsA, introducing what became known as the Vancouver criteria.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Subpopulations Within Juvenile Psoriatic Arthritis: A Review of the Literature

Stoll

Nigrović

2006

Journal of Immunology Research

View full text Add to dashboard Cite

The presentation of juvenile psoriatic arthritis (JPsA) has long been recognized to be clinically heterogeneous. As the definition of JPsA expanded to accommodate atypical manifestations of psoriasis in young children, studies began to reflect an increasingly clear biphasic distribution of age of onset, with peaks in the first few years of life and again in early adolescence. These two subpopulations differ in gender ratio, pattern of joint involvement, laboratory findings and potentially response to therapy. Intriguingly, a similar distribution of age of onset has been observed in juvenile rheumatoid arthritis (JRA), and correlates with patterns of HLA association. While a secure classification of subpopulations within JPsA awaits improved pathophysiologic understanding, future research must consider the possibility that different disease mechanisms may be operative in distinct subsets of patients with this disorder.

show abstract

supporting

confidence: 78%

mentioning

confidence: 99%

Subpopulations Within Juvenile Psoriatic Arthritis: A Review of the Literature

Stoll

Nigrović

2006

Journal of Immunology Research

View full text Add to dashboard Cite

show abstract

“…In children, however, arthritis may precede psoriasis in as many as 50% of cases. [24][25][26] PsA affects men and women equally, with a peak age of onset between 35 and 45 years of age. In children, PsA has a mean age of onset of 9 to 10 years, and may have a female predominance.…”

Section: Psoriatic Arthritis Key Pointsmentioning

confidence: 99%

Recognizing psoriatic arthritis in the dermatology clinic

Garg

Gladman

2010

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…The risk of developing sacroiliitis in patients with PsA is higher in males [16] and in HLA-B27-positive patients [17]. There may be a relationship between early onset oligoarthritis and psoriasis.…”

Section: Prognostic Factors In Psoriatic Juvenile Idiopathic Arthritismentioning

confidence: 99%

Prognostic factors in juvenile idiopathic arthritis

Prieur

Chédeville

2001

Curr Rheumatol Rep

View full text Add to dashboard Cite

Prognostic factors in juvenile arthritis are related to many variables that must be evaluated according to the different subtypes. The International League of Associations of Rheumatologists (ILAR) recently proposed six different categories referred to as the Durban criteria, under the eponym of juvenile idiopathic arthritis (JIA). The aim of this classification was to define homogeneous groups according to their clinical and biologic features. The prognostic factors were classified into the different categories of JIA. A poor outcome in the systemic form correlated with markers of disease activity, such as fever and polyarticular involvement, within the first 6 months. The risk of joint destruction in oligoarthritis correlated with the severity of arthritis within the first 2 years. Polyarthritis with positive rheumatoid factor is associated with marked disability in adulthood. In a group of psoriatic patients, the risk of developing sacroiliitis is higher in male and HLA-B27-positive patients. Patients with enthesitis-related arthritis with lower limb, knee, and tarsal involvement also are at greater risk of developing sacroiliitis. Chronic uveitis is a complication of JIA observed mainly in patients with oligoarthritis associated with positive antinuclear antibodies in serum. Secondary amyloidosis is observed mainly in children with systemic JIA. The long-term outcome must be discussed according to the various therapies. Corticosteroids contribute to growth retardation and osteoporosis, for which the use of human recombinant growth hormone and biphosphonates may be an option. Newer encouraging therapies such as anticytokines have been proposed for children with active disease. Autologous stem cell transplantation is being evaluated in some centers with promising results; however, it has a high rate of mortality. Further discussion regarding which patients should undergo autologous stem cell transplantation is needed, as is further discussion regarding the technical adaptations necessary.

show abstract

Juvenile psoriatic arthritis—an analysis of 60 cases

Cited by 122 publications

References 15 publications

Subpopulations Within Juvenile Psoriatic Arthritis: A Review of the Literature

Subpopulations Within Juvenile Psoriatic Arthritis: A Review of the Literature

Recognizing psoriatic arthritis in the dermatology clinic

Prognostic factors in juvenile idiopathic arthritis

Contact Info

Product

Resources

About